Evidence that T-cell-dependent B cell activation indeed occurs in the lungs comes also from the demonstration that highly somatically mutated ACPAs have been cloned from lungs of patients with RA as well as from ACPA-positive individuals at risk for RA [51]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.